Clinical Trial Update: Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety of a single inhaler containing beclometasone/formoterol for COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Beclometasone/Formoterol (beclometasone/formoterol)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED